ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -10.96% |
| Q3 2025 | 26.88% |
| Q2 2025 | 5.14% |
| Q1 2025 | 23.00% |
| Q4 2024 | -25.78% |
| Q3 2024 | 4.24% |
| Q2 2024 | 29.99% |
| Q1 2024 | 4.40% |
| Q4 2023 | -33.39% |
| Q3 2023 | 10.74% |
| Q2 2023 | -17.34% |
| Q1 2023 | -35.38% |
| Q4 2022 | 32.24% |
| Q3 2022 | -80.09% |
| Q2 2022 | 18.85% |
| Q1 2022 | 3.38% |
| Q4 2021 | 12.86% |
| Q3 2021 | -22.46% |
| Q2 2021 | -301.05% |
| Q1 2021 | 62.26% |
| Q4 2020 | -42.56% |
| Q3 2020 | -55.09% |
| Q2 2020 | 31.32% |
| Q1 2020 | -219.10% |
| Q4 2019 | 11.74% |
| Q3 2019 | 31.11% |
| Q2 2019 | -16.24% |
| Q1 2019 | 0.00% |